Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL.
Wenzl K, Stokes M, Novak JP, Bock AM, Khan S, Hopper MA, Krull JE, Dropik AR, Walker JS, Sarangi V, Mwangi R, Ortiz M, Stong N, Huang CC, Maurer MJ, Rimsza L, Link BK, Slager SL, Asmann Y, Mondello P, Morin R, Ansell SM, Habermann TM, Feldman AL, King RL, Nowakowski G, Cerhan JR, Gandhi AK, Novak AJ. Wenzl K, et al. Among authors: habermann tm. medRxiv [Preprint]. 2023 Jun 10:2023.06.07.23290748. doi: 10.1101/2023.06.07.23290748. medRxiv. 2023. Update in: Blood Cancer J. 2024 Jun 20;14(1):100. doi: 10.1038/s41408-024-01080-0 PMID: 37333387 Free PMC article. Updated. Preprint.
Primary Central Nervous System Lymphoma Tumor Biopsies Show Heterogeneity in Gene Expression Profiles, Genetic Subtypes, and in vitro Drug Sensitivity to Kinase Inhibitors.
Zhu YX, Wong JC, Hilal T, Maguire A, Ocal J, Zellner K, Chen X, Link BK, Habermann TM, Maurer MJ, Cerhan JR, Johnston PB, Feldman AL, Scott DW, Rosenthal A, Rimsza L. Zhu YX, et al. Among authors: habermann tm. medRxiv [Preprint]. 2024 Dec 6:2024.11.11.24316310. doi: 10.1101/2024.11.11.24316310. medRxiv. 2024. PMID: 39677423 Free PMC article. Preprint.
[No title available]
[No authors listed] [No authors listed] PMID: 39112421
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance.
Bock AM, Wenzl K, Novak JP, Stokes ME, Hopper MA, Krull JE, Dropik AR, Sarangi V, Ortiz M, Stong N, Huang CC, Maurer MJ, King RL, Farooq U, Wang Y, Witzig TE, Ansell SM, Habermann TM, Cerhan JR, Gandhi AK, Nowakowski G, Novak AJ. Bock AM, et al. Among authors: habermann tm. Hematol Oncol. 2025 Jan;43(1):e70006. doi: 10.1002/hon.70006. Hematol Oncol. 2025. PMID: 39612356 Free PMC article.
Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium.
Day JR, Larson MC, Durani U, Koff JL, Wang Y, Habermann TM, Lossos IS, Nastoupil LJ, Strouse CS, Chihara D, Martin P, Leonard JP, Cohen JB, Kahl BS, Ruan J, Burack R, Friedberg JW, Cerhan JR, Flowers CR, Link BL, Maurer MJ, Casulo C. Day JR, et al. Among authors: habermann tm. Blood Adv. 2024 Nov 27:bloodadvances.2024014053. doi: 10.1182/bloodadvances.2024014053. Online ahead of print. Blood Adv. 2024. PMID: 39602301
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.
Hopper MA, Dropik AR, Walker JS, Novak JP, Laverty MS, Manske MK, Wu X, Wenzl K, Krull JE, Sarangi V, Maurer MJ, Yang ZZ, Del Busso MD, Habermann TM, Link BK, Rimsza LM, Witzig TE, Ansell SM, Cerhan JR, Jevremovic D, Novak AJ. Hopper MA, et al. Among authors: habermann tm. Blood Cancer J. 2024 Oct 9;14(1):172. doi: 10.1038/s41408-024-01145-0. Blood Cancer J. 2024. PMID: 39384745 Free PMC article.
Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature.
Bommier C, Link BK, Gysbers BJ, Maurer MJ, Larson MC, Khurana A, Wang Y, Thompson CA, Chihara D, Alderuccio JP, Koff JL, Epperla N, Conconi A, Lossos IS, Nowakowski GS, Feldman AL, Habermann TM, King RL, Cerhan JR. Bommier C, et al. Among authors: habermann tm. Blood Adv. 2024 Dec 10;8(23):5939-5948. doi: 10.1182/bloodadvances.2024013188. Blood Adv. 2024. PMID: 39321424 Free PMC article.
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.
Abro B, Maurer MJ, Habermann TM, Burack WR, Chapman JR, Cohen JB, Friedberg JW, Inghirami G, Kahl BS, Larson MC, Link BK, Lossos IS, Martin P, McDonnell TJ, Nastoupil LJ, Riska SM, Syrbu S, Vega F, Vij KR, Flowers CR, Cerhan JR, Jaye DL, Feldman AL. Abro B, et al. Among authors: habermann tm. Blood. 2024 Nov 7;144(19):2063-2066. doi: 10.1182/blood.2024025681. Blood. 2024. PMID: 39255410
436 results